Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biofrontera AG (NASDAQ: BFRA).

Full DD Report for BFRA

You must become a subscriber to view this report.


Recent News from (NASDAQ: BFRA)

Institutional Top Ideas Series: Opaleye Management
In the last entry of this series, we took a look at top ideas from Ra Capital Management, the best performing fund we´ve come across so far with heavily concentrated positions in their top ideas. Going forward, I hope to continue to delve into the portfolios of successful hedge funds ...
Source: SeekingAlpha
Date: May, 17 2018 01:52
Wired News - FDA's Advisory Committee Supports Approval of Akcea's WAYLIVRA(TM) for Treatment of Familial Chylomicronemia Syndrome
Stock Monitor: Biofrontera Post Earnings Reporting LONDON, UK / ACCESSWIRE / May 15, 2018 / If you want access to our free research report on Akcea Therapeutics, Inc. (NASDAQ: AKCA) ("Akcea"), all you need to do is sign up now by clicking the following link www.active-investors.com/re...
Source: ACCESSWIRE IA
Date: May, 15 2018 07:30
Biofrontera reports FY results
Biofrontera (NASDAQ: BFRA ): FY EPS of €0.42. More news on: Biofrontera, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 30 2018 08:04
Biofrontera Reports Full Year 2017 Financial Results
Leverkusen, Germany, April 30, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, today reported its consolidated financial results for the full ye...
Source: GlobeNewswire
Date: April, 30 2018 08:00
Premarket analyst action - healthcare
Biofrontera (NASDAQ: BFRA ) initiated with Buy rating and $19 (35% upside) price target at Lake Street. More news on: Biofrontera, Biogen Inc., Edwards Lifesciences Corp, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: April, 25 2018 08:47
How Do Listed Companies Perform With A U.S. IPO?
US equity markets are an attractive source of capital and liquidity, even for companies that are already listed on foreign exchanges or the OTC markets. Frankfurt-listed MorphoSys (MOR) began trading on Thursday, and four more traded companies are currently scheduled to complete initial ...
Source: SeekingAlpha
Date: April, 19 2018 23:18
Biofrontera announces preliminary unaudited sales revenues for the 1st Quarter 2018
Leverkusen, Germany, April 12, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (ISIN: DE0006046113), the specialist for the treatment of sun-induced skin cancer, today announced preliminary unaudited revenue for the first quarter of fiscal year 2018. The preliminary unaudited revenu...
Source: GlobeNewswire
Date: April, 12 2018 10:52
Biofrontera AG Announces Partial Waiver of Lock-Up Agreement
LEVERKUSEN, Germany, March 15, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ:BFRA) (Frankfurt Stock Exchange:B8F) (the “Company”) announced today that The Benchmark Company, LLC, the managing underwriter of the Company’s recent initial public offering in the United St...
Source: GlobeNewswire
Date: March, 15 2018 10:15
Stocks To Watch: Back To Basics Time
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Investors head into next week with a bit of improved visibility after tariff exempt...
Source: SeekingAlpha
Date: March, 10 2018 09:27
U.S. IPO Weekly Recap: IPO Market Recovers In A Week With 4 Small Deals
Markets have rebounded, and volatility has settled. That's very good news for the IPO market, which is especially impacted by market turmoil . Right now, we're in annual February lull, and companies are putting off IPOs to finalize full 2017 financials and get past the Presidents' Day holid...
Source: SeekingAlpha
Date: February, 17 2018 06:47

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1713.7513.9413.9813.752,157

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-14200200100.0000Short
2018-08-131,4002,90148.2592Short
2018-08-02500500100.0000Short
2018-08-01500500100.0000Short
2018-07-311,4121,412100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BFRA.


About Biofrontera AG (NASDAQ: BFRA)

Logo for Biofrontera AG (NASDAQ: BFRA)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: BFRA)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 07 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 03 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 03 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 30 2018
      Annual and transition report of foreign private issuers under sections 13 or 15(d)
      Filing Type: 20-FFiling Source: edgar
      Filing Date: April, 30 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 26 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 19 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 12 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 28 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: March, 23 2018

       

       


      Daily Technical Chart for (NASDAQ: BFRA)

      Daily Technical Chart for (NASDAQ: BFRA)


      Stay tuned for daily updates and more on (NASDAQ: BFRA)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: BFRA)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BFRA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BFRA and does not buy, sell, or trade any shares of BFRA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/